Project Details
Abstract
我們預期降血糖藥物二甲雙胍可以影響腸道微菌叢的多樣性變化,從而調控體內的抗炎機制,改善Th17/Treg細胞的平衡狀態,達成影響糖尿病性骨病的表現與結果。完成本實驗,我們計畫可以進一步釐清出腸道微菌叢中的特定益生菌種,協助改善現行藥物的治療效果;甚者,延伸至骨質疏鬆症的初級預防作業。
Project IDs
Project ID:PC11007-2079
External Project ID:MOST110-2314-B182-006
External Project ID:MOST110-2314-B182-006
Status | Finished |
---|---|
Effective start/end date | 01/08/21 → 31/07/22 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.